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UNIT A2.1Imaging Dural Sinus Thrombosis
The acute onset of irreversible neurological deficit is referred to as a “stroke” and is the
third leading cause of death and the major cause of adult long-term disability in the United
States. (Fischbein et al., 2000). Obstruction of the venous sinuses by thrombosis accounts
for ∼1% of strokes. Thrombosis of the superior saggital sinus is most frequent, with
involvement of transverse, sigmoid, and cavernous sinuses less often. Venous thrombosis
may involve the dural sinuses, the deep venous system, and the superficial cortical veins
separately or in any combination.
Patients presenting with seizures more often have thrombosis of the superficial cortical
veins. These patients have a worse prognosis than those with isolated dural sinus
thrombosis. Early diagnosis and treatment significantly improve prognosis. Ideally,
therapy can be started before the patient has developed significant edema and/or hemor-
rhage. Mortality figures range from 20% to 75% with a trend of lowered rates with
increased availability of MRI.
In ∼40% of cases of dural sinus thrombosis, there is retrograde clot propagation into the
cortical or deep medullary veins. While the causes of venous thrombosis can be divided
into septic and aseptic etiologies, 25% remain unknown, being classified as idiopathic
(Fischbein et al., 2000).
BASIC
PROTOCOL
IMAGING DURAL SINUSES BY TIME-OF-FLIGHT MRV
Magnetic resonance imaging with magnetic resonance venography (MRV) is the tech-
nique of choice in the diagnosis and follow-up of cerebral venous thrombosis. Thrombosis
may be identified on spin echo images as an absence of the normal flow void. On MRV,
thrombosis manifests itself as lack of signal. Thrombus signal intensity differs on T1- and
T2-weighted spin echo images and evolves with the phases of hemoglobin degradation.
Recognition of artifacts and pitfalls related to MRI techniques is crucial to correctly
interpret the presence or absence of venous sinus thrombosis.
The following sequences comprise the authors’ preferred protocol for evaluating dural
sinus thrombosis, (1) three-plane positioning scout; (2) time-of-flight MRV; (3) non-
contrast spin echo sagittal T1-weighted; (4) non-contrast coronal turbo spin echo proton
density/T2-weighted; and (5) spin echo coronal with flow compensation. These imaging
sequences take ∼16 min and 3 sec of imaging time in addition to set up time between
sequences.
Table A2.1.1 lists the equipment needed to perform the following imaging sequences. The
available gradient strength will depend on the scanner, and the echo times given below
will be modified accordingly (i.e., the smaller the gradient strength, the longer the echo
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Table A2.1.1 Equipment Specifications Needed to Perform Imaging Sequences
Coil type Circularly polarized head coil
Field strength 1.5 T
Gradient strength Minimum of 15 mT/m
Positioning cushion or head
stabilizers
Yes
Knee cushion Yes
Use of contrast agents No
Pulse oximeter If patient requires sedation
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time for a particular scan). The authors use a Siemens Vision 1.5 T system, but they expect
to run the same sequences in this unit on other machines made by other MR manufacturers.
NOTE: Be sure that technologists and nurses have immediate access to any emergency
equipment that may be relevant to a given study, or that may be needed for a particular
patient, such as crash carts or oxygen.
Set up patient and equipment
1. Interview the patient to assess for contraindications such as cardiac pacemaker,
implanted mechanical devices, and/or ferromagnetic materials. Also, determine if the
patient will need sedation medication, which will necessitate the need for appropriate
monitoring equipment.
Each patient or legal guardian, prior to bringing the patient into the exam area, must sign
a screening form.
The presence of ferromagnetic materials may be a health hazard to the patient while in the
magnetic field and/or adversely affect image quality. To determine the safety of scanning
such ferromagnetic materials, see Shellock (1996).
The presence of ferromagnetic materials in the globe of the eye is contraindicated for MRI.
Patients with prior metal exposure to the eye should have plain X-rays of the orbital area
to ensure that all metal has been removed prior to placing them in the magnetic field
(Shellock, 1996).
2. If the procedure is a research protocol, have the patient sign any necessary consent
form.
3. Request the patient to change into a gown and remove all personal effects such as,
jewelry, hearing aids, glasses, etc., prior to entering the MRI scan room. All personal
belongings should be secured during the examination.
4. Have the patient wash off any mascara and other makeup to avoid local tissue heating
and artifacts.
5. Explain the procedure to the patient and record relevant clinical history. Ensure that
the patient understands what is expected and ask if he or she has questions. Answer
appropriately.
6. Set up the exam room by securing the circularly polarized (CP)-head coil onto the
table and providing a clean exam table.
7. Escort the patient to the MR examination room and position him or her according to
the exam to be performed. Review the following items with the patient:
a. Provide earplugs or headphones to the patient to minimize the gradient noise but
assure the patient that the patient should still be able to hear you.
b. Provide the patient with a safety squeeze-bulb and demonstrate how it works.
Explain to the patient that he or she may use the squeeze-bulb if assistance is
needed during the exam.
c. Explain to the patient that you will be talking to him or her between imaging
sequences that will be when the loud knocking noise stops.
d. Explain to the patient that it is imperative that he or she remains motionless during
the loud knocking noise to ensure good results. Also, explain that they should not
reposition their body between imaging sequences.
e. The patient may call out at any time if he or she feels it necessary.
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f. Provide the patient with an estimate of the examination length. Although the total
scan time is 16 min and 3 sec, because of set-up time between sequences, tell the
patient that this exam will take ∼20 min.
8. Position a support under the patient’s knees to enhance comfort.
9. If the patient is unable to hold still, provide appropriate sedation.
10. Secure the patient’s head with positioning sponges or head stabilizers.
11. Center the patient’s nasion to the coil using the laser light.
12. Advance the patient couch to isocenter.
Sequence 1: Rapid three-plane positioning scout
13. To validate the patient’s position and to have a reference to prescribe successive
imaging sequences, acquire a three-plane orthogonal scout sequence. See Table
A2.1.2 for specific parameters. Run the scan.
Most MR scanners can be programmed to acquire the scout automatically after coil tuning
or after the patient has been placed in isocenter (for systems that do not require tuning).
Siemens acquires the scout in three planes by selecting “various.”
Sequence 2: Time-of-flight MRV–sagittal sinus
14. Display both the sagittal and transverse scout images in two separate quadrants on
the scan monitor.
15. Change imaging parameters to those listed in Table A2.1.3. Position slices to midline
of the transverse scout with a sagittal to coronal angle of approximately −12° (this
will reduce in-plane saturation effects). Position the presaturation band off the sagittal
scout image angled in a manner to saturate the facial sinuses (be sure not to “clip”
any of the sagittal sinus).
16. Instruct the patient to remain motionless, as the scan will begin and last for ∼9 min.
Run a time-of-flight magnetic resonance venogram (MRV) of the superior sagittal
sinus according to the parameters in Table A2.1.3.
This sequence is most important in demonstrating flow within the dural sinuses as well as
potentially showing the location and cause of obstruction including thrombi.
Sequence 3: Noncontrast spin echo sagittal T1-weighted sequence
17. Some patients have this examination because of findings noted on a routine cranial
MR. If not already provided as a part of a recent study, run a noncontrast spin echo
sagittal T1-weighed scan using the parameters in Table A2.1.4.
Sequence 4: Noncontrast coronal multiecho spin echo
18. Run a noncontrast coronal multiecho scan according to Table A2.1.5. This is a dual
echo turbo spin echo sequence that acquires both proton density and T2-weighted
images simultaneously.
In this study, look for normal flow voids in the venous sinuses. These flow voids may be
compromised by signal from blood products on T2-weighted images. There tend to be fewer
of these artifacts on the proton density weighted images. The proton density weighted
images come as a bonus with the T2-weighted images without any additional expenditure
of time and they are useful in this situation.
Sequence 5: Spin echo coronal with flow compensation
19. Run a spin echo coronal scan according to the parameters in Table A2.1.6.
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Table A2.1.2 Imaging Parameters for Sequence 1: Scout Sequence
Patient position Supine
Scan type Gradient echo
Imaging plane (orientation) Transverse, sagittal, coronal
(various)
Central slice or volume center Nasion
Echo time (TE) 6 msec
Repeat time (TR) 15 msec
Flip angle (FA) 30°
Field of view (FOVx, FOVy) 300 mm, 300 mm
Resolution (∆x, ∆y) 1.17 mm, 2.34 mm
Number of data points collected (Nx, Ny) 256, 128
Slice thickness (∆z) 8 mm
Number of slices 3 (one per orientation)
Slice gap Not applicable
Number of acquisitions (Nacq) 1
Swap read and phase encoding No
Slice location Not applicable
Saturation pulses Not applicable
Slice series Ascending caudal to cranial
Scan time 7 sec
Table A2.1.3 Imaging Parameters for Sequence 2: Time-of-Flight MRV of the
Sagittal Sinus
Patient position Supine
Scan type 2-D gradient echo
Imaging plane (orientation) Sagittal
Central slice or volume center Slices centered to midline on
transverse scout
Echo time (TE) 9 msec
Repeat time (TR) 30 msec
Flip angle (FA) 50°
Field of view (FOVx, FOVy) 210 mm, 210 mm
Resolution (∆x, ∆y) 0.82 mm, 0.82 mm
Number of data points collected (Nx, Ny) 256, 256
Slice thickness (∆z) 3 mm
Number of slices 64
Slice gap 1 mm
Number of acquisitions (Nacq) 1
Swap read and phase encoding No
Slice location Angle sagittal to coronal −12° (to
reduce in-plane saturation) off
transverse scout image
Saturation pulses Yes, one angled through facial
sinus area off sagittal scout image,
60-mm thick
Slice series Ascending
Scan time 6 min, 43 sec
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Table A2.1.4 Imaging Parameters for Sequence 3: Spin Echo Sagittal
T1-Weighted Sequence
Patient position Supine
Scan type Spin echo
Imaging plane (orientation) Sagittal
Central slice or volume center Slices centered to midline on
transverse scout
Echo time (TE) 14 msec
Repeat time (TR) 510 msec
Flip angle (FA) 90°
Field of view (FOVx, FOVy) 230 mm, 230 mm
Resolution (∆x, ∆y) 0.90 mm, 0.95 mm
Number of data points collected (Nx, Ny) 256, 243
Slice thickness (∆z) 6 mm
Number of slices 17
Slice gap 1.8 mm
Number of acquisitions (Nacq) 1
Swap read and phase encoding No
Slice location Equidistant between left and right
brain
Saturation pulses No
Slice series Interleaved
Scan time 2 min, 7 sec
Table A2.1.5 Imaging Parameters for Sequence 4: Coronal Turbo Spin Echo
Proton Density (PD)/T2-Weighted Images
Patient position Supine
Scan type Turbo spin echo (dual echo)
Imaging plane (orientation) Coronal
Central slice or volume center Slices centered to midbrain on
sagittal scout
Echo time (TE) 15 msec and 105 msec
Echo train length (ETL) 7
Repeat time (TR) 4500 msec
Flip angle (FA) 180°a
Field of view (FOVx, FOVy) 230 mm, 230r mm, with r = 3/4
(rectangular field of view)
Resolution (∆x, ∆y) 0.90 mm, 0.90 mm
Number of data points collected (Nx, Ny) 256, 256r, with r = 3/4
(rectangular field of view)
Slice thickness (∆z) 5 mm
Number of slices 24
Slice gap 1.5 mm
Number of acquisition (Nacq) 1
Swap read and phase encoding No
Slice location Equidistant between anterior and
posterior brain
Saturation pulses No
Slice series Interleaved
Scan time 2 min, 3 sec
aThe system displays the flip angle of the refocusing pulse. The flip angle of the first pulse of this
sequence is 90°.
Current Protocols in Magnetic Resonance Imaging Supplement 9
A2.1.5
Cerebral Venous
Lesions
Siemens calls this sequence gradient motion rephasing (GMR). It is very helpful in reducing
flow related artifact that may hinder evaluation of dural sinuses, particularly in the
posterior fossa. This sequence also accentuates the visibility of vessels, especially rapidly
flowing blood. This is useful when the vein is narrow or there is a thin rim of flow around
the periphery of a thrombus.
COMMENTARY
Background Information
Expectations have risen in the medical com-
munity to the point where clinicians expect to
rule in or out dural thrombosis using noninva-
sive techniques. MR is the modality of choice
in identifying and following treatment of dural
thrombosis (Bianchi et al., 1998). MR may
identify both the intravascular thrombus and the
concomitant parenchymal complications. Pa-
tients may present with rapid or insidious onset
of symptoms. Some patients present with rapid
onset of altered consciousness and focal neuro-
logical deficits. Others present with gradual
confusion, headache, papilledema, and cranial
nerve palsies from increased intracranial pres-
sure. Complications include cerebral edema,
infarction, hemorrhage, hydrocephalus, and
death. Predisposing factors are listed in the
following table (Table A2.1.7; Cure and Van
Tassel, 1994).
In involved veins, flow voids may be re-
placed by abnormal signal. The specific appear-
ance of the abnormality varies according to the
age of the thrombus and the imaging parameters
used. The parenchymal findings vary with the
stage of the process from normal to swelling
with interstitial edema and subcortical hyper-
intensity on proton density weighted and T2-
weighted images, and in the more severe case
will include the presence of hematoma (Tsai et
al., 1995).
Table A2.1.6 Imaging Parameters for Sequence 5: T1-Weighted Spin Echo
Coronal with Flow Compensation
Patient position Supine
Scan type Spin echo
Imaging plane (orientation) Coronal
Central slice or volume center Slices centered to midbrain on
sagittal scout
Echo time (TE) 17 msec
Repeat time (TR) 532 msec
Flip angle (FA) 90°
Field of view (FOVx, FOVy) 230 mm, 230r mm, with r = 3/4
(rectangular field of view)
Resolution (∆x, ∆y) 0.90 mm, 0.90 mm
Number of data points collected (Nx, Ny) 256, 256r, with r = 3/4
(rectangular field of view)
Slice thickness (∆z) 5 mm
Number of slices 19
Slice gap 1.5 mm
Number of acquisitions (Nacq) 2
Swap read and phase encoding No
Slice location Center midway anterior to
posterior brain
Flow compensation Yes
Saturation pulses No
Slice series Interleave
Scan time 3 min, 26 sec
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Critical Parameters
The authors routinely use time-of-flight for
MRV. Occasionally, phase-contrast techniques
are used if there is a question about direction
of flow or if there is a problem with shine-
through from thrombus (for more information
about phase contrast sequences, see the exam-
ple given in UNIT A1.1, Table A1.1.8). The diag-
nosis of venous sinus thrombosis is supported
by the absence of flow-related enhancement or
motion-related phase shift. Because of its T1
shortening, methemoglobin may exhibit shine-
through and mimic a patent sinus on time-of-
flight MRV. Findings must be correlated with
those of T1-weighted images. Phase-contrast
MRV is a background subtraction technique
and tends to eliminate signal from thrombus
and hematomas. Phase-contrast MRV could be
used when unable to resolve this problem with
time-of-flight MRV and conventional T1-
weighted images (Yuh et al., 1994).
Anticipated Results
The goal in studying cerebral dural sinuses
is to identify thrombosis and to allow the choice
of timely treatment options. Interpretation of
cerebral MRI examinations has potential for
both false-positive and false-negative errors.
Slow flow may simulate venous thrombosis on
spin echo images creating a false positive find-
ing. A false negative finding may be present
with time-of-flight MRV in patients who have
actual venous thrombosis. Here methemoglo-
bin is a natural breakdown product present in
clot. The T1-shortening effects of methemoglo-
bin can “shine-through” giving the illusion of
Table A2.1.7 Factors Predisposing to Cerebral Venous Thrombosis
Aseptic Septic
Hematologic disorders
Sickle cell disease Encephalitis
Meningitis
Leukemia Mastoiditis
Sinusitis
Thrombocytopenia Sepsis
Cellulitis
Empyema subdural or epidural
Disseminated intravascular coagulopathy
Anticardiolipin syndrome
Deficiencies: protein S, protein C,
antithrombin III
Neoplasia
Direct compression
Invasion of dural sinus
Hypercoagulability
Dehydration
Infants
Pregnancy & puerperium
Trauma
Drugs
Oral contraceptives
L–asparaginase
Dural AVF
Inflammatory conditions
Ulcerative colitis
Behcet’s disease
Idiopathic
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a patent venous channel. The background sub-
traction technique of phase-contrast MRV may
be helpful. This technique eliminates bright
signal from stationary thrombus and hema-
tomas (Fischbein et al., 2000). The following
are some examples.
An 18-year-old male with sickle cell anemia
has occlusion of his superior sagittal sinus with
increased T1 signal related to thrombus with
methemoglobin formation (Fig. A2.1.1).
A 25-year-old pregnant female who has a
hypercoagulable state presented with superior
sagittal sinus thrombosis. There is total occlu-
sion of most of her superior sagittal sinus with
increased T1 signal (Fig. A2.1.2). This is less
intense than on the previous examination sug-
Figure A2.1.1 Superior sagittal thrombosis with bright T1 signal from
thrombus.
Figure A2.1.2 Superior sagittal sinus thrombosis with in-
creased T1 signal. This is less bright than the previous exam-
ple.
Current Protocols in Magnetic Resonance Imaging
A2.1.8
Imaging Dural
Sinus Thrombosis
gesting that the clot is older than the one seen
on the previous example (Fig. A2.1.1).
A 34-year-old man with leukemia has supe-
rior sagittal sinus thrombosis with clot that is
almost isointense with brain (Fig. A2.1.3). The
clot is older than the two previous examples.
This is considerably less conspicuous than the
two previous examples. With less signal throm-
bus may be overlooked on conventional T1-
weighted images.
A 28-year-old female has occlusion of her
transverse sinus with increased T1 signal related
to methemoglobin within the thrombus (Fig.
A2.1.4). This much T1 signal has the potential
to cause “shine-through” artifact on MRV. Her
only known risk factor was the use of oral
Figure A2.1.3 Superior sagittal sinus thrombosis with T1 signal,
which is almost isointense with brain.
Figure A2.1.4 Occlusion of transverse sinus with high T1
signal in clot.
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contraceptives and kept this case from being
classified as idiopathic.
A 68-year-old male with thrombocytopenia
has superior sinus thrombosis with partial
blockage of the sinus (Fig. A2.1.5). Some flow
is still demonstrated in the expected lumen of
the sinus. The presence or absence of flow is
better appreciated on MRV than on other se-
quences.
A 40-year-old female with disseminated in-
travascular coagulopathy has total occlusion of
the superior sagittal sinus, the inferior sagittal
sinus, the straight sinus and parts of the trans-
verse sinuses (Fig. A2.1.6).
A 25-year-old male with mastoiditis had
thrombosis of the right transverse sinus (Fig.
A2.1.7 and Fig. A2.1.8). A conventional cranial
MRI had demonstrated mastoiditis with in-
creased T2 signal in the region of mastoid air
cells on the side of the thrombosis.
Figure A2.1.6 Superior sagittal sinus thrombosis with total occlu-
sion on MRV.
Figure A2.1.5 Superior sagittal sinus thrombosis with partial blockage
on MRV.
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Figure A2.1.8 Occlusion transverse sinus on coronal MRV.
Figure A2.1.7 Occlusion transverse sinus on transverse
MRV.
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These authors describe the importance of MRI and
MRV in the diagnosis and follow-up of cerebral
venous thrombosis. They point out how different
signals on spin echo T1- and T2-weighted images
evolve according to hemoglobin degradation caus-
ing pitfalls and artifacts that must be recognized.
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Covers a number of important patient management
issues related to MR imaging, including recom-
mended safety procedures, a list of metallic implants
that have been tested for MR compatibility, and a
list of other sources on MR safety.
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